While a Limited Liability Partnership (LLP) is an excellent starting structure for clinical groups or local diagnostic operations, it presents major limitations when trying to scale a national HealthTech platform or execute pharmaceutical drug development. Venture capital funds and institutional equity investors cannot invest in LLPs due to statutory constraints. Converting the LLP into a Private Limited company unlocks the ability to issue equity shares, design employee stock options, and build an attractive corporate architecture for global scaling.
When a growing Limited Liability Partnership (LLP) outgrows its capital structure and needs access to venture capital, institutional funding, or ESOP programs, converting into a Private Limited Company is the necessary next step. Because LLPs do not have share capital, equity-based fundraising and VC investments are structurally impossible. We execute this corporate transformation under Section 366 of the Companies Act, 2013 (Part I conversion), which allows the statutory vesting of all LLP assets, liabilities, and intellectual property directly into the new corporate entity. This specialized process ensures that your existing client contracts, licenses, and operational history are preserved automatically, preventing the complex, tax-heavy asset transfer or slump sale procedures that alternative conversion routes demand.
HealthTech companies developing complex medical AI or digital health systems require significant VC funding to scale operations and clear regulatory hurdles. Since VCs universally require a Private Limited structure to acquire shares, converting the LLP is the primary step to passing institutional investor due diligence and securing crucial series-funding rounds.
Attracting world-class software engineers, clinical trial coordinators, and data scientists requires competitive compensation packages that include equity. A Private Limited structure allows the establishment of a structured Employee Stock Option Plan (ESOP). This compensation tool is legally impossible under an LLP structure, giving a powerful mechanism to align staff incentives with long-term corporate growth.
Utilize the Part I conversion pathway to ensure all assets, properties, and legal contracts transfer directly to the company by operation of law.
Manage the strict publication of newspaper notices (Form URC-2) and the preparation of CA-certified statements of assets and liabilities.
Draft formal partner resolutions and unanimous consents, establishing a clean shareholding pattern that mirrors prior partnership stakes.
Assist in preparing and securing formal No Objection Certificates (NOCs) from secured and unsecured creditors to ensure a smooth ROC approval.
The LLP must have at least two partners (who will become the shareholders and directors of the company), all pending MCA filings (Form 8 and Form 11) must be completely clear, and you must obtain written NOCs from all secured creditors.
Under the Income Tax Act, the transition is tax-exempt if all partners become shareholders in the same proportion as their capital accounts, no cash settlements are made, and the partners retain at least 50% voting power for five years.
Under MCA rules, we must publish a public notice of conversion in Form URC-2 in two prominent local newspapers (one English and one vernacular) in the district of the LLP’s registered office. We manage the drafting, publication, and 21-day objection period tracking.
Comprehensive solutions tailored perfectly to your industry.
Resolve income tax notices and scrutiny assessments with precise, portal-compliant responses.
